The European Medicines Agency (EMA), in response to a request from the German news agency, said that experts from the European Medicines Agency (EMA) are investigating cases of myocarditis that have occurred in people who have been vaccinated against Covid-19 using Pfizer / BioNTech and Moderna preparations. He stressed that “at the present time, there is no indication that these cases are related to the vaccine.”
The European regulator added that the high incidence of myocarditis was also linked to COVID-19 itself. The agency did not say how many cases of myocarditis it studied.
According to the information provided by EMA to dpa, The cases identified were reported in subjects vaccinated with preparations based on mRNA technology. Vaccines approved for use in the European Union to date include Moderna and Pfizer / BionNTech.
Recently, the Israeli Ministry of Health, which uses the Pfizer / BionTech vaccine almost exclusively, said it would analyze the small number of cases of myocarditis in people who were vaccinated with the preparation. It has been confirmed that It is unclear if the number of cases is above normal and whether it is related to vaccination.
There are 62 cases of myocarditis among the more than 5 million vaccinated people, especially after the second dose of the preparation and in men younger than 30 years of age. As dpa wrote, two people died – a woman and a man.
Cardiologist at the Schwabing Clinic in Munich, Bernard Nagel explained to dpa that myocarditis usually occurs in men under the age of 50. In my opinion it is The mRNA vaccine is unlikely to be associated with this condition. Additionally, the risk of developing cardiovascular disease is greater and more at risk if you develop Covid-19 – He said. In most cases, he added, myocarditis can be treated with medication.